Bioprocessing of Human Stem Cells Applied to Diseases of the Central Nervous System

............................................................................................................................... II ACKNOWLEDGEMENTS ........................................................................................................... III IN MEMORIAM ........................................................................................................................ V TABLE OF CONTENTS .............................................................................................................. VI LIST OF TABLES ..................................................................................................................... XIII LIST OF FIGURES ................................................................................................................... XIV NOMENCLATURE ................................................................................................................ XVIII

[1]  Hassan Azari,et al.  Isolation and expansion of the adult mouse neural stem cells using the neurosphere assay. , 2010, Journal of visualized experiments : JoVE.

[2]  Michael S. Kallos,et al.  Effects of Hydrodynamics on Cultures of Mammalian Neural Stem Cell Aggregates in Suspension Bioreactors , 2001 .

[3]  A. Morton,et al.  Striatal Transplantation in a Transgenic Mouse Model of Huntington's Disease , 1998, Experimental Neurology.

[4]  Anders Björklund,et al.  Prospects for new restorative and neuroprotective treatments in Parkinson's disease , 1999, Nature.

[5]  X.L. Chen,et al.  Deep Brain Stimulation , 2013, Interventional Neurology.

[6]  S. Gerson,et al.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.

[7]  H. Lassmann.  Pathology and disease mechanisms in different stages of multiple sclerosis , 2013, Journal of the Neurological Sciences.

[8]  Jie Pan,et al.  Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. , 2013, Stem cells and development.

[9]  G. Nikkhah,et al.  Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells , 2008, Experimental Neurology.

[10]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[11]  J. Glass,et al.  Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients , 2012, Stem cells.

[12]  M. Hayden,et al.  BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice , 2010, The Journal of Neuroscience.

[13]  A. Vescovi,et al.  Mild Hypoxia Enhances Proliferation and Multipotency of Human Neural Stem Cells , 2010, PloS one.

[14]  L. Rosenberg,et al.  Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. , 2010, Cytotherapy.

[15]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[16]  E. Cattaneo,et al.  Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.

[17]  C. Gamba,et al.  Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson's disease , 2012, Journal of Neuroimmunology.

[18]  Su-Chun Zhang,et al.  Human Embryonic Stem Cell‐Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats , 2008 .

[19]  F. Rossi,et al.  Neuroprotection: The Emerging Concept of Restorative Neural Stem Cell Biology for the Treatment of Neurodegenerative Diseases , 2011, Current neuropharmacology.

[20]  Suk-Ho Lee,et al.  Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. , 2011, The Journal of clinical investigation.

[21]  C. Lois,et al.  Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Ted M. Dawson,et al.  Animal Models of PD Pieces of the Same Puzzle? , 2002, Neuron.

[23]  Arnold I Caplan,et al.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models , 2012, Nature Neuroscience.

[24]  Mark Stacy,et al.  Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease , 2006, Annals of neurology.

[25]  B. Pérez-Köhler,et al.  Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells , 2010, Journal of cellular physiology.

[26]  Deepti Mathur,et al.  Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease. , 2006, Indian journal of experimental biology.

[27]  P. Rakic,et al.  Neural Stem Cells: Historical Perspective and Future Prospects , 2011, Neuron.

[28]  M. Sospedra,et al.  Immunology of Multiple Sclerosis , 2016, Seminars in Neurology.

[29]  M. Grãos,et al.  The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations , 2012, Stem Cell Research & Therapy.

[30]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[31]  Robert J. Thomas,et al.  Expansion of human mesenchymal stem cells on microcarriers , 2011, Biotechnology Letters.

[32]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[33]  I. Gussi,et al.  Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells , 2013, Stem Cell Research & Therapy.

[34]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[35]  M. Hong,et al.  Intrastriatal and Intranigral Grafting of hNT Neurons in the 6-OHDA Rat Model of Parkinson's Disease , 2000, Experimental Neurology.

[36]  F M Watt,et al.  Out of Eden: stem cells and their niches. , 2000, Science.

[37]  M. Mcgrogan,et al.  Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease , 2010, Journal of neuroscience research.

[38]  P. Naveilhan,et al.  Expression of Heme Oxygenase‐1 in Neural Stem/Progenitor Cells as a Potential Mechanism to Evade Host Immune Response , 2012, Stem cells.

[39]  Joshua M Hare,et al.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.

[40]  M. Hong,et al.  Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft , 2000, The Journal of comparative neurology.

[41]  D. Hwang,et al.  Stem cells as promising therapeutic options for neurological disorders , 2013, Journal of cellular biochemistry.

[42]  Dieter Eibl,et al.  Dynamic Single-Use Bioreactors Used in Modern Liter- and m(3)- Scale Biotechnological Processes: Engineering Characteristics and Scaling Up. , 2014, Advances in biochemical engineering/biotechnology.

[43]  Elaine Fuchs,et al.  Stem Cells A New Lease on Life , 2000, Cell.

[44]  Jonas Frisén,et al.  Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome , 2005, Nature Neuroscience.

[45]  B. Thébaud,et al.  Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. , 2012, Stem cells and development.

[46]  M. S. Kallos,et al.  Improved expansion of human bone marrow‐derived mesenchymal stem cells in microcarrier‐based suspension culture , 2014, Journal of tissue engineering and regenerative medicine.

[47]  Hongxin Dong,et al.  Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats , 2012, Journal of the Neurological Sciences.

[48]  L. Lejeune,et al.  Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. , 2005, Blood.

[49]  M. S. Kallos,et al.  Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. , 1999, Biotechnology and bioengineering.

[50]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.

[51]  S. Dunnett,et al.  Cell therapy in Huntington’s disease , 2004, NeuroRX.

[52]  U. Wyneken,et al.  Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[53]  Jacques Galipeau,et al.  The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? , 2013, Cytotherapy.

[54]  Yang D. Teng,et al.  Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells , 2007, Proceedings of the National Academy of Sciences.

[55]  Rüdiger Klein,et al.  Neuron–astrocyte communication and synaptic plasticity , 2010, Current Opinion in Neurobiology.

[56]  Karim Mukhida,et al.  Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats. , 2008, Neurosurgical focus.

[57]  Carsten R. Bjarkam,et al.  New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders , 2004, Biogerontology.

[58]  J. Lévesque,et al.  Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. , 2008, Stem cells and development.

[59]  Alan J Thompson,et al.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study , 2012, The Lancet Neurology.

[60]  N. Baldini,et al.  Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy , 2012, Front. Physio..

[61]  M. Emborg,et al.  Intracerebral Transplantation of Differentiated Human Embryonic Stem Cells to Hemiparkinsonian Monkeys , 2013, Cell transplantation.

[62]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[63]  E. Mirzaei,et al.  Differentiation Potential of Human Bone Marrow Mesenchymal Stem Cells into Motorneuron-like Cells on Electrospun Gelatin Membrane , 2014, Journal of Molecular Neuroscience.

[64]  R. Roth,et al.  Survival and Integration of Neurons Derived from Human Embryonic Stem Cells in MPTP-Lesioned Primates , 2014, Cell transplantation.

[65]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[66]  D E H Tee,et al.  Book Review: Culture of Animal Cells: A Manual of Basic Technique , 1984 .

[67]  E. Bieberich,et al.  Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell–derived neural transplants , 2004, The Journal of cell biology.

[68]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[69]  G. Lemon,et al.  Viability and proliferation of rat MSCs on adhesion protein-modified PET and PU scaffolds. , 2012, Biomaterials.

[70]  G. Bell,et al.  Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. , 2012, Stem cells and development.

[71]  H. Geiger,et al.  Adipose-Derived Mesenchymal Stromal/Stem Cells: Tissue Localization, Characterization, and Heterogeneity , 2012, Stem cells international.

[72]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[73]  S. Dunnett,et al.  Cell transplantation for Huntington's disease Should we continue? , 2007, Brain Research Bulletin.

[74]  R. Romieu-Mourez,et al.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing , 2011, Cytotherapy.

[75]  S. Totey,et al.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. , 2010, Translational research : the journal of laboratory and clinical medicine.

[76]  S. Gill,et al.  GDNF delivery for Parkinson's disease. , 2007, Acta neurochirurgica. Supplement.

[77]  L. Rosenberg,et al.  Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum‐free medium , 2012, Journal of tissue engineering and regenerative medicine.

[78]  H. Hatta,et al.  Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. , 2006, BioFactors.

[79]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[80]  S. Kyurkchiev,et al.  Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitro , 2008, Cell biology international.

[81]  Karim Mukhida,et al.  Expansion of Human Neural Precursor Cells in Large‐Scale Bioreactors for the Treatment of Neurodegenerative Disorders , 2008, Biotechnology progress.

[82]  J. Gimble,et al.  Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. , 2011, Tissue engineering. Part C, Methods.

[83]  S. Pluchino,et al.  The stem cell secretome and its role in brain repair , 2013, Biochimie.

[84]  A. Ghavamzadeh,et al.  Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. , 2007, Iranian journal of immunology : IJI.

[85]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[86]  R. Fields,et al.  New insights into neuron-glia communication. , 2002, Science.

[87]  K. Mukhida,et al.  Spinal GABAergic Transplants Attenuate Mechanical Allodynia in a Rat Model of Neuropathic Pain , 2007, Stem cells.

[88]  T. Deacon,et al.  Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. , 1996, Cell transplantation.

[89]  A. Björklund,et al.  Neural transplantation for the treatment of Parkinson's disease , 2003, The Lancet Neurology.

[90]  J. Yun,et al.  Phenotype analysis in patients with early onset Parkinson’s disease with and without parkin mutations , 2011, Journal of Neurology.

[91]  I. Ferrer,et al.  BDNF Up‐Regulates TrkB Protein and Prevents the Death of CA1 Neurons Following Transient Forebrain Ischemia , 1998, Brain pathology.

[92]  T. Zhao,et al.  Characteristics of Neural Stem Cells Expanded in Lowered Oxygen and the Potential Role of Hypoxia-Inducible Factor-1Alpha , 2007, Neurosignals.

[93]  G. Nappi,et al.  Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease , 2010, Brain Research.

[94]  M. Dragunow,et al.  The role of neuronal growth factors in neurodegenerative disorders of the human brain , 1998, Brain Research Reviews.

[95]  A. Salgado,et al.  The secretome of bone marrow mesenchymal stem cells‐conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures) , 2011, Journal of tissue engineering and regenerative medicine.

[96]  J. Goverman.  Immune tolerance in multiple sclerosis , 2011, Immunological reviews.

[97]  M. Chopp,et al.  Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease , 2001, Neuroscience Letters.

[98]  R. Cherry,et al.  Transient shear stresses on a suspension cell in turbulence , 1990, Biotechnology and bioengineering.

[99]  M. Chopp,et al.  Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice , 2005, Experimental Neurology.

[100]  S. Frucht,et al.  Treatment of Parkinson’s Disease , 2005, CNS drugs.

[101]  J. Gimble,et al.  Impact of low oxygen on the secretome of human adipose-derived stromal/stem cell primary cultures. , 2013, Biochimie.

[102]  S. Pluchino,et al.  Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials , 2014, Experimental Neurology.

[103]  P. Riederer,et al.  Understanding Parkinson's disease. , 1997, Scientific American.

[104]  Nameeta Shah,et al.  Large-Scale Production of Human Glioblastoma-Derived Cancer Stem Cell Tissue in Suspension Bioreactors to Facilitate the Development of Novel Oncolytic Therapeutics , 2011 .

[105]  J Tramper,et al.  Shear sensitivity of animal cells from a culture-medium perspective. , 1998, Trends in biotechnology.

[106]  Wang Yanyun,et al.  Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro , 2011, Neuroreport.

[107]  M. Chesselet,et al.  Genetic mouse models of parkinsonism: Strengths and limitations , 2005, NeuroRX.

[108]  M. Beal,et al.  Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes , 2006, Nature Medicine.

[109]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[110]  Nic D. Leipzig,et al.  Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. , 2009, Stem cells and development.

[111]  Byung‐Soo Kim,et al.  Mammalian cell cultivation on serum-coated microcarriers , 1992 .

[112]  Maria Teresa Dell'Anno,et al.  Direct generation of functional dopaminergic neurons from mouse and human fibroblasts , 2011, Nature.

[113]  C. Chao,et al.  Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. , 2013, Clinical science.

[114]  G. Nikkhah,et al.  Clinical neurotransplantation protocol for Huntington's and Parkinson's disease. , 2013, Restorative neurology and neuroscience.

[115]  Yan Sun,et al.  Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. , 2012, Cell stem cell.

[116]  D. Prou,et al.  Toxin-induced models of Parkinson’s disease , 2005, NeuroRX.

[117]  E. Putnins,et al.  Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. , 2007, Biomaterials.

[118]  I. Leroi,et al.  Treatment of the psychiatric aspects of Huntington's Disease: a review of the literature. , 1998 .

[119]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[120]  Antonio Uccelli,et al.  Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis , 2007, Annals of neurology.

[121]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[122]  B. Jin,et al.  The role of neuroinflammation on the pathogenesis of Parkinson's disease. , 2010, BMB reports.

[123]  C. Götherström.  Immunomodulation by mesenchymal stem cells and clinical experience , 2011 .

[124]  V. Bolshakov,et al.  ES cell-derived renewable and functional midbrain dopaminergic progenitors , 2011, Proceedings of the National Academy of Sciences.

[125]  M. S. Kallos,et al.  Bioreactor expansion of human neural precursor cells in serum‐free media retains neurogenic potential , 2009, Biotechnology and bioengineering.

[126]  Reid L Skeel,et al.  Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease , 2010, Behavioural Brain Research.

[127]  M. Saito,et al.  Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. , 2002, Osteoarthritis and cartilage.

[128]  M. Butler.  Animal Cell Culture and Technology , 1997 .

[129]  A. Asawachaicharn,et al.  Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis , 2006, Experimental Neurology.

[130]  Lingxin Kong,et al.  Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease , 2005, Brain Research.

[131]  J. Ringe,et al.  A Microcarrier‐Based Cultivation System for Expansion of Primary Mesenchymal Stem Cells , 2007, Biotechnology progress.

[132]  W. le Gros Clark.  The problem of neuronal regeneration in the central nervous system: II. The insertion of peripheral nerve stumps into the brain. , 1943, Journal of anatomy.

[133]  Y. Chern,et al.  Human Mesenchymal Stem Cells Prolong Survival and Ameliorate Motor Deficit through Trophic Support in Huntington's Disease Mouse Models , 2011, PloS one.

[134]  T. Kilpatrick,et al.  Effects of Bone Morphogenic Proteins on Neural Precursor Cells and Regulation during Central Nervous System Injury , 2009, Neurosignals.

[135]  Joseph B. Martin,et al.  Patterns of cell loss in Huntington's disease , 1987, Trends in Neurosciences.

[136]  Luigi Murri,et al.  Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis , 2008, Neuropsychiatric disease and treatment.

[137]  D. Brooks,et al.  Glial cell line–derived neurotrophic factor induces neuronal sprouting in human brain , 2005, Nature Medicine.

[138]  N. Patel,et al.  GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2013, Pharmacology & therapeutics.

[139]  R. Vandlen,et al.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.

[140]  K. Mukhida,et al.  A review of bioreactor protocols for human neural precursor cell expansion in preparation for clinical trials. , 2011, Current stem cell research & therapy.

[141]  B. Raaka,et al.  Human Islet‐Derived Precursor Cells Are Mesenchymal Stromal Cells That Differentiate and Mature to Hormone‐Expressing Cells In Vivo , 2007, Stem cells.

[142]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[143]  D. Prockop,et al.  “Stemness” Does Not Explain the Repair of Many Tissues by Mesenchymal Stem/Multipotent Stromal Cells (MSCs) , 2007, Clinical pharmacology and therapeutics.

[144]  M. Tuszynski,et al.  Growth-factor gene therapy for neurodegenerative disorders , 2002, The Lancet Neurology.

[145]  A. Sbarbati,et al.  Adipose‐Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis , 2009, Stem cells.

[146]  M. Chopp,et al.  Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice , 2006, Journal of neuroscience research.

[147]  W. Schultz.  Getting Formal with Dopamine and Reward , 2002, Neuron.

[148]  D. Lara,et al.  Increased Plasma Levels of Brain Derived Neurotrophic Factor (BDNF) in Patients with Fibromyalgia , 2010, Neurochemical Research.

[149]  J. Kesslak,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease , 2001 .

[150]  A. Björklund,et al.  Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease , 2013, The Lancet Neurology.

[151]  P. Andrade,et al.  Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. , 2010, Journal of biotechnology.

[152]  M S Croughan,et al.  Hydrodynamic effects on animal cells grown in microcarrier cultures , 1987, Biotechnology and bioengineering.

[153]  D. Panchision,et al.  The role of oxygen in regulating neural stem cells in development and disease , 2009, Journal of cellular physiology.

[154]  Douglas R Martin,et al.  Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2 , 2009, Experimental Neurology.